Adamas Announces New Employment Inducement Grant

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) has granted restricted stock units to four new employees, allowing them to acquire 44,500 shares of common stock. These units will vest over three years and are part of the 2016 Inducement Plan, established to attract new talent to the company. This initiative underscores Adamas' commitment to building a robust workforce aimed at developing innovative treatments for neurological diseases, reflecting its strategic focus on enhancing its portfolio and addressing patient needs.

Positive

• Granting of 44,500 restricted stock units to new employees enhances employee retention and motivation.
• The issuance is part of a strategic plan to attract talent, indicating growth potential.

Negative

• None.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new employees restricted stock units to acquire 44,500 shares of the company’s common stock. The restricted stock units vest over three years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210709005438/en/

FAQ

What is the recent stock grant announcement by Adamas Pharmaceuticals on Nasdaq: ADMS?

Adamas Pharmaceuticals announced the granting of 44,500 restricted stock units to four new employees, which will vest over three years.

How many shares were granted to employees by Adamas Pharmaceuticals?

Adamas Pharmaceuticals granted a total of 44,500 shares through restricted stock units.

What is the purpose of the restricted stock units granted by Adamas Pharmaceuticals?

The restricted stock units were granted to attract and retain new employees as part of the 2016 Inducement Plan.

What is the vesting period for the stock units granted by Adamas Pharmaceuticals?

The restricted stock units will vest over a period of three years.